Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952756 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Major Histocompatibility Complex, Class II, DQ alpha 1 (HLADQA1) (N-Term), (AA 46-74) antibody
- Antibody type
- Polyclonal
- Antigen
- KLH conjugated synthetic peptide between 46-74 amino acids from the N-terminal region of human HLA-DQA1
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term,AA 46-74
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.
Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL, Lane JA, Lavant E, Rappner R, Louey A, Concannon P, Mychaleckyj JC, Erlich HA, Type 1 Diabetes Genetics Consortium.
Diabetes 2010 Nov;59(11):2972-9
Diabetes 2010 Nov;59(11):2972-9
Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, Day CP, Aithal GP
Journal of hepatology 2010 Dec;53(6):1049-53
Journal of hepatology 2010 Dec;53(6):1049-53
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS